India Coronavirus Vaccine Research Report 2025: $1.25 Bn Market Opportunities, Competition, Forecasts 2020-2030 - Expanding Healthcare in Tier 2 and 3 Cities, an…

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

Shingles Vaccine Research Report 2025: Market to Reach $9.6 Billion by 2029, Driven by Aging Population, Recombinant Vaccine Innovation, and Expanding Adult Immu…

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Mayo Clinic on MSN

COVID-19 vaccines: Get the facts

The 2025-2026 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and Novavax. The vaccines are all approved for people age 65 and older. Each vaccine also is approved ...
WVIK

Augustana professor of biology stresses the importance of vaccines ahead of the fall upper respiratory virus season

Residents without insurance or underinsured can contact the Rock Island and Scott County Public Health Department to inquire ...
Medscape

Respiratory Syncytial Virus Protein Structure, Function and Implications for Subunit Vaccine Development

CHF: Congestive heart failure; CLD: Chronic lung disease; F: Fusion; G: Glyco; GLA-SE: Glucopyranosyl lipid A-stable emulsion; GMT: Geometric mean titer; M: Matrix;NA ...
Seeking Alpha

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

PRINCETON, N.J., Sept. 4, 2025 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat ...